Dr Reddy’s, Alvotech partner to develop and commercialize biosimilar of cancer drug Keytruda
- Posted on June 5, 2025
- By Financial Express
- 3 Views
Dr Reddy’s, Alvotech partner to develop and commercialize biosimilar of cancer drug Keytruda
Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda (pembrolizumab), for global markets.
